BSEQualitek Labs LimitedMediumPositive
Announced Mon, 19 Oct, 2026 · 14:22 IST

Subsidiary wins work order from Meghalaya govt for lab setup

Govt Defence OrderBusiness Updates View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹553.00
prior close
₹541.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%+0.9% vs market
Consulting Services peers, median of 17sector-2.0%+1.1% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.1 pts more than its Consulting Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.2
10m
-2.2
15m
-2.2
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8-1.7+0.9-2.0+1.1
Next day
-4.5-4.2-0.3-4.3-0.3
2d
-2.4-5.2+2.9-5.2+2.8
3d
-5.1-7.4+2.4-6.9+1.8
4d
-8.7-7.0-1.6-7.5-1.2
5d
-10.7pendingpending-3.8-6.9
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Consulting Services peers, median of 17Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Qualitek Labs' wholly owned subsidiary Interstellar Testing Centre has received a work order from Bio-Resources Development Centre (BRDC), a Government of Meghalaya research institution under its Science and Technology department, for setting up, operating and getting accreditation for a Quality Control and Analytical Laboratory at BRDC Experimental Farm in Upper Shillong, Meghalaya. The order is domestic, falls within the normal course of business, and has no related party interest. Order value and execution timeline were not disclosed citing commercial confidentiality.

Likely market impact

Adds a new government-backed revenue stream for the subsidiary's lab services business, though undisclosed order value limits near-term visibility.